Regulation of atrial natriuretic peptide receptors in vascular smooth muscle cells: Role of cGMP

L. M. Zhang, H. Tao, W. H. Newman

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

We tested the hypothesis that intracellular guanosine 3',5'-cyclic monophosphate (cGMP) regulates atrial natriuretic peptide (ANP) receptors. The effect of chronic exposure to ANP, sodium nitroprusside (SNP), and 8- bromo-cGMP (8-BrcGMP) on ANP receptors and cGMP formation was determined in guinea pig thoracic aorta smooth muscle cells (TASM) and in coronary artery smooth muscle cells (CASM). TASM express both the ANP-activated guanylyl cyclase (B-receptor) and the clearance receptor (C-receptor) and respond to ANP with increased cGMP. CASM exhibit only the ANP C-receptor. In TASM, 24-h treatment with 1 μM atriopeptin (AP) III [rat ANP-(103-126)] caused a sixfold increase in basal cGMP levels, which were unaltered in CASM. In AP III-treated TASM, maximal binding of 125I-labeled AP III (B(max)) was reduced 40% while affinity [dissociation constant (K(D))] was unaltered. In CASM, B(max) and K(D) were not affected. In treated TASM, washed free of AP III, acute dose-response curves of cGMP to AP III were not different from that in untreated cells. In both TASM and CASM, basal cGMP levels were elevated and B(max) was decreased by 6-h treatment with SNP. SNP did not alter the acute response of cGMP to AP III. In both cell types, 8-BrcGMP for 6 h caused reduction in B(max). These findings support the conclusion that elevated cGMP was necessary for ANP-induced downregulation of receptors. The unaltered responsiveness of cGMP to AP III suggests the B-receptor was not altered and the reduced B(max) was due to decreased C-receptor.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume264
Issue number6 33-6
StatePublished - Jan 1 1993

Fingerprint

Atrial Natriuretic Factor Receptors
Vascular Smooth Muscle
Smooth Muscle Myocytes
Thoracic Aorta
Atrial Natriuretic Factor
Coronary Vessels
Nitroprusside
Cyclic GMP
atrial natriuretic factor prohormone (103-126)
Guinea Pigs

Keywords

  • 8- bromoguanosine 3',5'-cyclic monophosphate
  • atrial natriuretic peptide receptor regulation
  • particulate and soluble guanylyl cyclase
  • sodium nitroprusside
  • vascular smooth muscle cells

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Regulation of atrial natriuretic peptide receptors in vascular smooth muscle cells : Role of cGMP. / Zhang, L. M.; Tao, H.; Newman, W. H.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 264, No. 6 33-6, 01.01.1993.

Research output: Contribution to journalArticle

@article{eb8260fc95f2483a969945057734e516,
title = "Regulation of atrial natriuretic peptide receptors in vascular smooth muscle cells: Role of cGMP",
abstract = "We tested the hypothesis that intracellular guanosine 3',5'-cyclic monophosphate (cGMP) regulates atrial natriuretic peptide (ANP) receptors. The effect of chronic exposure to ANP, sodium nitroprusside (SNP), and 8- bromo-cGMP (8-BrcGMP) on ANP receptors and cGMP formation was determined in guinea pig thoracic aorta smooth muscle cells (TASM) and in coronary artery smooth muscle cells (CASM). TASM express both the ANP-activated guanylyl cyclase (B-receptor) and the clearance receptor (C-receptor) and respond to ANP with increased cGMP. CASM exhibit only the ANP C-receptor. In TASM, 24-h treatment with 1 μM atriopeptin (AP) III [rat ANP-(103-126)] caused a sixfold increase in basal cGMP levels, which were unaltered in CASM. In AP III-treated TASM, maximal binding of 125I-labeled AP III (B(max)) was reduced 40{\%} while affinity [dissociation constant (K(D))] was unaltered. In CASM, B(max) and K(D) were not affected. In treated TASM, washed free of AP III, acute dose-response curves of cGMP to AP III were not different from that in untreated cells. In both TASM and CASM, basal cGMP levels were elevated and B(max) was decreased by 6-h treatment with SNP. SNP did not alter the acute response of cGMP to AP III. In both cell types, 8-BrcGMP for 6 h caused reduction in B(max). These findings support the conclusion that elevated cGMP was necessary for ANP-induced downregulation of receptors. The unaltered responsiveness of cGMP to AP III suggests the B-receptor was not altered and the reduced B(max) was due to decreased C-receptor.",
keywords = "8- bromoguanosine 3',5'-cyclic monophosphate, atrial natriuretic peptide receptor regulation, particulate and soluble guanylyl cyclase, sodium nitroprusside, vascular smooth muscle cells",
author = "Zhang, {L. M.} and H. Tao and Newman, {W. H.}",
year = "1993",
month = "1",
day = "1",
language = "English (US)",
volume = "264",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "6 33-6",

}

TY - JOUR

T1 - Regulation of atrial natriuretic peptide receptors in vascular smooth muscle cells

T2 - Role of cGMP

AU - Zhang, L. M.

AU - Tao, H.

AU - Newman, W. H.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - We tested the hypothesis that intracellular guanosine 3',5'-cyclic monophosphate (cGMP) regulates atrial natriuretic peptide (ANP) receptors. The effect of chronic exposure to ANP, sodium nitroprusside (SNP), and 8- bromo-cGMP (8-BrcGMP) on ANP receptors and cGMP formation was determined in guinea pig thoracic aorta smooth muscle cells (TASM) and in coronary artery smooth muscle cells (CASM). TASM express both the ANP-activated guanylyl cyclase (B-receptor) and the clearance receptor (C-receptor) and respond to ANP with increased cGMP. CASM exhibit only the ANP C-receptor. In TASM, 24-h treatment with 1 μM atriopeptin (AP) III [rat ANP-(103-126)] caused a sixfold increase in basal cGMP levels, which were unaltered in CASM. In AP III-treated TASM, maximal binding of 125I-labeled AP III (B(max)) was reduced 40% while affinity [dissociation constant (K(D))] was unaltered. In CASM, B(max) and K(D) were not affected. In treated TASM, washed free of AP III, acute dose-response curves of cGMP to AP III were not different from that in untreated cells. In both TASM and CASM, basal cGMP levels were elevated and B(max) was decreased by 6-h treatment with SNP. SNP did not alter the acute response of cGMP to AP III. In both cell types, 8-BrcGMP for 6 h caused reduction in B(max). These findings support the conclusion that elevated cGMP was necessary for ANP-induced downregulation of receptors. The unaltered responsiveness of cGMP to AP III suggests the B-receptor was not altered and the reduced B(max) was due to decreased C-receptor.

AB - We tested the hypothesis that intracellular guanosine 3',5'-cyclic monophosphate (cGMP) regulates atrial natriuretic peptide (ANP) receptors. The effect of chronic exposure to ANP, sodium nitroprusside (SNP), and 8- bromo-cGMP (8-BrcGMP) on ANP receptors and cGMP formation was determined in guinea pig thoracic aorta smooth muscle cells (TASM) and in coronary artery smooth muscle cells (CASM). TASM express both the ANP-activated guanylyl cyclase (B-receptor) and the clearance receptor (C-receptor) and respond to ANP with increased cGMP. CASM exhibit only the ANP C-receptor. In TASM, 24-h treatment with 1 μM atriopeptin (AP) III [rat ANP-(103-126)] caused a sixfold increase in basal cGMP levels, which were unaltered in CASM. In AP III-treated TASM, maximal binding of 125I-labeled AP III (B(max)) was reduced 40% while affinity [dissociation constant (K(D))] was unaltered. In CASM, B(max) and K(D) were not affected. In treated TASM, washed free of AP III, acute dose-response curves of cGMP to AP III were not different from that in untreated cells. In both TASM and CASM, basal cGMP levels were elevated and B(max) was decreased by 6-h treatment with SNP. SNP did not alter the acute response of cGMP to AP III. In both cell types, 8-BrcGMP for 6 h caused reduction in B(max). These findings support the conclusion that elevated cGMP was necessary for ANP-induced downregulation of receptors. The unaltered responsiveness of cGMP to AP III suggests the B-receptor was not altered and the reduced B(max) was due to decreased C-receptor.

KW - 8- bromoguanosine 3',5'-cyclic monophosphate

KW - atrial natriuretic peptide receptor regulation

KW - particulate and soluble guanylyl cyclase

KW - sodium nitroprusside

KW - vascular smooth muscle cells

UR - http://www.scopus.com/inward/record.url?scp=0027200929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027200929&partnerID=8YFLogxK

M3 - Article

C2 - 8391754

AN - SCOPUS:0027200929

VL - 264

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 6 33-6

ER -